Company / SG&A Expense
Henry Schein SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$3.1B
FY2025
5-year range
$2.6B / $3.1B
FY2021-FY2025
Trend
+1.6%
vs FY2024
Sector context
#19 of 158
Health Care
What the data says
Henry Schein's sg&a expense of $3.1B is higher than 88% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 10 years, ranging from $2.1B in FY2019 to $3.1B in FY2025.
Based on SEC 10-K filings.
$3.1B in FY2025 with a 5-year CAGR of +8.1%. Top quartile in the Health Care sector.
Increased from $2.6B to $3.1B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 158This company $3.1B Sector average $175.9B
▼
-98.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 1.6% year-over-year.
- Ranks #19 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2019.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.1B | +1.6% |
| FY2024 | $3.0B | +15.2% |
| FY2023 | $2.6B | -4.9% |
| FY2022 | $2.8B | +5.2% |
| FY2021 | $2.6B | +26.3% |
| FY2020 | $2.1B | +0.7% |
| FY2019 | $2.1B | -6.6% |
| FY2018 | $2.2B | +7.0% |
| FY2017 | $2.1B | -14.0% |
| FY2016 | $2.4B | +7.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026